Vanderbilt- Ingram Cancer Center — Nashville, Tennessee

Vanderbilt- Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232-6307.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Vanderbilt- Ingram Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site.

Sponsors: Celgene, SCRI Development Innovations, LLC.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt- Ingram Cancer Center?

Vanderbilt- Ingram Cancer Center has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt- Ingram Cancer Center conducted?

Vanderbilt- Ingram Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site.

Is Vanderbilt- Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt- Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt- Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.